Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

RESTASIS ® Ophthalmic Emulsion contains cyclosporine. How does this affect the safety profile of RESTASIS ® ?

April 26, 2017affect Cyclosporine emulsion ophthalmic profile RESTASIS safety

0

Posted

RESTASIS ® Ophthalmic Emulsion contains cyclosporine. How does this affect the safety profile of RESTASIS ® ?

1 Answer

0

Posted

RESTASIS ® Ophthalmic Emulsion has a favorable safety profile. In fact, in clinical studies, there was no increase in infection, interaction with other drugs, increase in intraocular pressure, or detectable systemic drug absorption in the blood for up to 12 months of treatment. The delivery vehicle for cyclosporine in RESTASIS ® is a unique, oil-based ophthalmic emulsion. This emulsion technology provides effective drug delivery to ocular tissue and is effective with a very low cyclosporine concentration (0.05%).